Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.44 |
| ▸ | F7 | P08709 | 3/20 | 0.44 |
| ▸ | F3 | P13726 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PPARD | Q03181 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1552085 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL16186905 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL18944632 | 0.90 | ADORA3 (0.49) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL1551789 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL1551784 | 0.82 | ALDH1A1 (0.53) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL17307884 | 0.78 | ALDH1A1 (0.57) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL17307880 | 0.78 | ADORA3 (0.59) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL17307883 | 0.77 | ALDH1A1 (0.60) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL1550735 | 0.77 | ALDH1A1 (0.44) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL1550738 | 0.77 | ALDH1A1 (0.44) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12465580-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF AS (NO) | 2025-11-11 | — | — | US | disclosed |
| EP-3288550-B1 | STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR THEIR USE IN TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2024-06-05 | — | — | EP | disclosed |
| US-20240156760-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2024-05-16 | — | — | US | disclosed |
| US-11911354-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF (NO) | 2024-02-27 | — | — | US | disclosed |
| US-20220280459-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2022-09-08 | — | — | US | disclosed |
| US-11234948-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF AS (NO) | 2022-02-01 | — | — | US | disclosed |
| US-10722481-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF AS (NO) | 2020-07-28 | — | — | US | disclosed |
| US-20200085772-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2020-03-19 | — | — | US | disclosed |
| US-20190314304-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | PRONOVA BIOPHARMA NORGE AS (NO) | 2019-10-17 | — | — | US | disclosed |
| US-20180104201-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR PREVENTING AND OR TREATING NON ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2018-04-19 | — | — | US | disclosed |
| EP-3288550-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Pronova BioPharma Norge AS (NO) | 2018-03-07 | — | — | EP | disclosed |
| US-20170029368-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS | 2017-02-02 | — | — | US | disclosed |
| WO-2016173923-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | PRONOVA BIOPHARMA NORGE AS (NO) | 2016-11-03 | — | — | WO | disclosed |
| EP-2313090-B1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2016-03-30 | — | — | EP | disclosed |
| US-20140316002-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-10-23 | — | — | US | disclosed |
| US-8759558-B2 | Sulphur containing lipids for use as food supplement or as medicament | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-06-24 | — | — | US | disclosed |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-08-04 | — | — | US | disclosed |
| EP-2313090-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | Pronova BioPharma Norge AS (NO) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010008299-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180104201-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR PREVENTING AND OR TREATING NON ALCOHOLIC STEATOHEPATITIS | FABP1, SLC10A1, LIPC | ALDH1A1 266/4885CYP3A4 1143/4885ALOX15 194/4885 |
| US-12465580-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885CYP3A4 1020/4885ALOX15 166/4885 |
| US-20140316002-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | SGMS2, SGMS1, ACSS2 | ALDH1A1 514/4885CYP3A4 1779/4885ALOX15 226/4885 |
| US-20170029368-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | SGMS2, SGMS1, FABP2 | ALDH1A1 472/4885CYP3A4 2222/4885ALOX15 232/4885 |
| US-20240156760-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885CYP3A4 1020/4885ALOX15 166/4885 |
| US-11234948-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885CYP3A4 1020/4885ALOX15 166/4885 |
| US-10722481-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885CYP3A4 1020/4885ALOX15 166/4885 |
| US-20190314304-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | SLC10A1, FABP1, LIPC | ALDH1A1 462/4885CYP3A4 1271/4885ALOX15 155/4885 |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | SGMS2, SGMS1, ACSS2 | ALDH1A1 514/4885CYP3A4 1779/4885ALOX15 226/4885 |
| US-20200085772-A1 | USE OF STRUCTURALLY ENHANCED FATTY ACIDS FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | SLC10A1, FABP1, LIPC | ALDH1A1 462/4885CYP3A4 1271/4885ALOX15 155/4885 |
| US-20220280459-A1 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885CYP3A4 1020/4885ALOX15 166/4885 |
| US-11911354-B2 | Substituted fatty acids for treating non-alcoholic steatohepatitis | SLC10A1, LIPC, FABP1 | ALDH1A1 443/4885CYP3A4 1020/4885ALOX15 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.